Usefulness of rapid-acting insulin lispro in CSII

被引：0
|
作者：
Yanagisawa, K
Tuchida, KI
Endo, M
Masuda, H
Makita, Z
Koike, T
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A446 / A446
页数：1
相关论文
共 50 条
  • [41] The Revolution in Rapid-Acting Antidepressants
    Sanacora, Gerard
    Duman, Ronald S.
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 73 (12) : 1123 - 1124
  • [42] AFRESA™ Suppresses Endogenous Glucose Production Earlier Than a Rapid-Acting Analog (Lispro) and Inhaled Exubera®
    Potocka, Elizabeth
    Hovorka, Roman
    Baughman, Robert A.
    Umpleby, Margot
    Diaz, Mella Louise M.
    Chen, Ru
    Boss, Anders H.
    Richardson, Peter C.
    [J]. DIABETES, 2009, 58 : A61 - A61
  • [43] Ultra rapid lispro (URLi) shows faster insulin absorption vs lispro during insulin pump (CSII) use in patients with type 1 diabetes
    Kazda, C.
    Leohr, J.
    Liu, R.
    Hardy, T. A.
    Reddy, S.
    Chua, S. P. C.
    Guo, X.
    Hovelmann, U.
    Kapitza, C.
    [J]. DIABETOLOGIA, 2018, 61 : S401 - S401
  • [44] Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
    Fordan, Steve
    Raskin, Philip
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 225 - 231
  • [45] Is Subcutaneous Administration of Rapid-Acting Insulin as Effective as Intravenous Insulin for Treating Diabetic Ketoacidosis?
    Mazer, Maryann
    Chen, Esther
    [J]. ANNALS OF EMERGENCY MEDICINE, 2009, 53 (02) : 259 - 263
  • [46] Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus
    Danne, Thomas
    [J]. CLINICAL THERAPEUTICS, 2007, 29 : S145 - S152
  • [47] A New Rapid-Acting Antidepressant
    Krystal, John H.
    Charney, Dennis S.
    Duman, Ronald S.
    [J]. CELL, 2020, 181 (01) : 7 - 7
  • [48] Budget impact analysis of different rapid-acting insulin analogues in Italy
    Lanati, Elena P.
    La Malfa, Paola
    Iorio, Arianna
    Mennini, Francesco S.
    Fanelli, Francesca
    Gentile, Sandro
    [J]. GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2018,
  • [49] Pharmacodynamic properties of Viaject™:: A novel rapid-acting regular human insulin
    Steiner, Solomon S.
    Hompesch, Marcus
    Pohl, Roderike
    Simms, Patrick
    Pfuetzner, Andreas
    Forst, Thomas
    Heinemann, Lutz
    [J]. DIABETES, 2006, 55 : A27 - A27
  • [50] Insulin Biosimilars: The Impact on Rapid-Acting Analogue-Based Therapy
    S. Franzè
    F. Cilurzo
    P. Minghetti
    [J]. BioDrugs, 2015, 29 : 113 - 121
12345